BET FRX LLC v. Rebecca Myers

CourtCourt of Chancery of Delaware
DecidedApril 27, 2022
DocketC.A. No. 2019-0894-KSJM
StatusPublished

This text of BET FRX LLC v. Rebecca Myers (BET FRX LLC v. Rebecca Myers) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BET FRX LLC v. Rebecca Myers, (Del. Ct. App. 2022).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

BET FRX LLC, on behalf of itself and ) derivatively on behalf of FRX ) GROWTH, LLC, a Delaware limited ) liability company, ) ) Plaintiff, ) ) v. ) C.A. No. 2019-0894-KSJM ) REBECCA MYERS, DIETRICH ) STEPHAN, JOY BOCHNER, THE ) VILLAGE OF EASTBROOK, LLC, ) LIPIZZANER, LLC, and CIELO E ) MAR, LLC, ) ) Defendants, ) ) and ) ) FRX GROWTH, LLC, ) a Delaware limited liability company, ) ) Nominal Defendant, ) ) and ) ) FARMACEUTICALRX, LLC, ) ) Intervening Defendant. )

MEMORANDUM OPINION

Date Submitted: February 15, 2022 Date Decided: April 27, 2022

Sean M. Brennecke, KLEHR HARRISON HARVEY BRANZBURG LLP, Wilmington, Delaware; Jordan M. Rand, KLEHR HARRISON HARVEY BRANZBURG LLP, Philadelphia, Pennsylvania; Counsel for Plaintiff BET FRX LLC.

Samuel T. Hirzel, II, Jamie L. Brown, HEYMAN ENERIO GATTUSO & HIRZEL LLP, Wilmington, Delaware; Eric R. Levine, Eric Aschkenasy, EISEMAN LEVINE LEHRHAUPT & KAKOYIANNIS, P.C., New York, New York; Counsel for Defendants Rebecca Myers, Dietrich Stephan, Joy Bochner, the Village of Eastbrook, LLC, Lipizzaner, LLC, and Cielo E Mar, LLC.

Geoffrey G. Grivner, Kody M. Sparks, BUCHANAN INGERSOLL & ROONEY PC, Wilmington, Delaware; Kathleen Jones Goldman, BUCHANAN INGERSOLL & ROONEY PC, Pittsburgh, Pennsylvania; Counsel for Intervenor FarmaceuticalRX, LLC.

McCORMICK, C. A minority member of a limited liability company sued the other members and their

principals. The plaintiff alleges that after it invested eight million dollars into the nominal

defendant, the other members and their principals funneled that investment into a company

that they owned, and in which neither the plaintiff nor the nominal defendant had an

interest. The plaintiff brought this litigation to recoup its investment. The plaintiff took a

“kitchen sink” approach in the complaint, asserting claims for breach of the express and

implied terms of the LLC agreement and for judicial dissolution. The plaintiff also asserted

claims for breach of fiduciary duties directly and derivatively.

Most of the plaintiff’s claims are clearly deficient and this decision makes quick

work of them. The plaintiff’s claims for breach of the express and implied terms of the

LLC agreement fail because the plaintiff fails to identify any express or implied terms

allegedly breached. The plaintiff’s claim for judicial dissolution fails because the plaintiff

does not plead any factual basis for such relief. The plaintiff’s direct claim for breach of

fiduciary duties fails because the alleged harm is to the nominal defendant only. That

leaves one close call—the plaintiff’s claim for breach of fiduciary duties asserted

derivatively, which is adequately alleged. Except as to the close call, this decision grants

the defendants’ motion to dismiss.

I. FACTUAL BACKGROUND

The facts are drawn from the Verified Amended Complaint (the “Amended

Complaint”) and exhibits thereto.1

1 C.A. No. 2019-0894-KSJM, Docket (“Dkt.”) 31 (“Am. Compl.”). A. FarmaRX, FRX, And Plaintiff

FarmaceuticalRX, LLC (“FarmaRX”) is a Pennsylvania company formed to obtain

a Medical Marijuana Grower and Processor License (the “License”) from the

Commonwealth of Pennsylvania.

In 2015, Defendants Rebecca Myers, Dietrich Stephan, and Joy Bochner

(collectively, the “Individual Defendants”) acquired 90% of the membership interests in

FarmaRX. The Individual Defendants acquired their interest through their respective

investment vehicles, The Village of Eastbrook, LLC (“Eastbrook”), Lipizzaner, LLC

(“Lipizzaner”), and Cielo E Mar, LLC (“Cielo,” together with Eastbrook and Lipizzaner,

the “LLC Defendants,” and with the Individual Defendants, “Defendants”).

The Pennsylvania Department of Health awarded FarmaRX the License on July 31,

2018.

Around April 2019, Myers and Stephan began searching for outside investors to

fund FarmaRX’s operations. To facilitate an investment, the Individual Defendants formed

FRX Growth LLC (“FRX”) and exchanged their interests in FarmaRX for interests in FRX.

Through the transaction, FRX became the majority owner of FarmaRX. FRX has held an

85.21% membership interest in FarmaRX at all relevant times.

On May 16, 2019, Plaintiff BET FRX LLC (“Plaintiff” or “BET”) acquired 50% of

the membership units of FRX from the Individual Defendants for $8,000,000 (the “BET

Investment”). FRX loaned the BET Investment to FarmaRX pursuant to a promissory note

dated May 16, 2019.

2 B. The Governing Agreements

In connection with Plaintiff’s investment, the parties executed the First Amended

and Restated Operating Agreement of FRX dated as of May 16, 2019 (the “LLC

Agreement”). A few provisions of the LLC Agreement are germane to the parties’ dispute.

Section 8.01 provides that FRX is to be “managed, operated, and controlled by or

under the direction of” a three-member board of managers (the “FRX Board”). BET is

entitled to appoint one of the Managers (the “BET Manager”). The remaining two

managers are to be designated by a majority of the members other than BET. At all relevant

times, Douglas Topkis has served as the BET Manager and Myers and Stephan have served

as the Managers unaffiliated with BET.

Section 8.05(a) defines board quorum to require the BET Manager’s presence. The

upshot is that, although the FRX Board may approve most board actions by a majority vote,

the BET Manager must participate in every board decision.

Section 8.05(d) identifies sixteen types of actions that require the approval of the

BET Manager, which effectively grants the BET Manager a veto right over these actions.

They include: dissolution of FRX; increases in the authorized number of membership units;

redemption or repurchase of membership units by FRX; the issuance of additional

membership units by FRX; and the incurrence by FRX of any indebtedness greater than

$100,000. The list of sixteen actions does not include loans by FarmaRX or FRX to other

entities nor related-party transactions.

3 C. The Challenged Transaction

Myers and Stephan have an interest in an Ohio-based medical marijuana company

(the “Ohio Company”).2

Myers caused FarmaRX to loan $2 million of the BET Investment to fund the Ohio

Company’s growth.3 Before filing the Amended Complaint, Plaintiff deposed Julia Wnek,

2 The Amended Complaint alleges both that Myers was the sole owner of the Ohio Company and that Myers and Stephan were co-owners of the Ohio Company. Compare id. ¶¶ 92, 97, 103 (“[u]sing the BET Investment proceeds to pay companies wholly owned by Myers”), with id. ¶ 73 (“Myers’ and Stephan’s Ohio Company”); id. ¶ 74 (“Myers and Stephan utilized their control over FRX to funnel money . . . to fund operations at their Ohio Company”); id. ¶ 83 (“Stephan is a member of FRX’s Board and an owner of the Ohio Company”). This decision gives Plaintiff the benefit of the allegation that Stephan co-owns the Ohio Company. 3 Plaintiff’s Amended Complaint and answering brief contain contradictory factual allegations. The Amended Complaint alleges that Myers and Stephan funneled money into FarmaRX. Id. ¶ 74. The answering brief alleges both that Myers solely funneled money to the Ohio Company and that Myers and Stephan funneled money to the Ohio Company. Compare Dkt. 37 (“Pl.’s Answering Br.”) at 6 (“Myers and Stephan, acting through FRX, caused FarmaRX to issue an undocumented loan [to] the Ohio Company” (citing Am. Compl. ¶ 67)), with id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Tooley v. Donaldson, Lufkin, & Jenrette, Inc.
845 A.2d 1031 (Supreme Court of Delaware, 2004)
Wal-Mart Stores, Inc. v. AIG Life Insurance
901 A.2d 106 (Supreme Court of Delaware, 2006)
Clinton v. Enterprise Rent-A-Car Co.
977 A.2d 892 (Supreme Court of Delaware, 2009)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Cede & Co. v. Technicolor, Inc.
634 A.2d 345 (Supreme Court of Delaware, 1994)
Allied Capital Corp. v. GC-Sun Holdings, L.P.
910 A.2d 1020 (Court of Chancery of Delaware, 2006)
Price v. E.I. DuPont De Nemours & Co.
26 A.3d 162 (Supreme Court of Delaware, 2011)
In Re Walt Disney Co. Derivative Litigation
906 A.2d 27 (Supreme Court of Delaware, 2006)
Lonergan v. EPE HOLDINGS LLC
5 A.3d 1008 (Court of Chancery of Delaware, 2010)
Nationwide Emerging Managers, LLC v. Northpointe Holdings, LLC
112 A.3d 878 (Supreme Court of Delaware, 2015)
Gerber v. Enterprise Products Holdings, LLC
67 A.3d 400 (Supreme Court of Delaware, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
BET FRX LLC v. Rebecca Myers, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bet-frx-llc-v-rebecca-myers-delch-2022.